GABRIELA CRISTINA MILLA GODOY MD
Prescription History 1164083499
Internal Medicine in Boston, MA

Active since June 26, 2019PECOS EnrolledAccepts Medicare Assignment
15 FRANCIS ST # STREETA4, BOSTON, MA 02115(617) 732-8881(617) 732-6829 Get Directions

NPPES record last updated: February 14, 2023. Verified against the NPPES registry weekly; last sync: October 25, 2026.

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for GABRIELA CRISTINA MILLA GODOY MD, an active Internal Medicine specialist practicing in Boston, MA. Our medical registry currently tracks 5 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 127 documented patient claims. Among these therapy options, the most frequently utilized medication is Biktarvy, which accounts for 56 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

5
Medications
127
Total Claims
185
30-Day Fills
Biktarvy
Most Prescribed · 56 claims
View details
5 medications · 2024 Medicare Part D
Medicare Part D medications prescribed by GABRIELA CRISTINA MILLA GODOY MD in 2024, with prescription volumes, average cost per fill, and MA state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other MA PrescribersVs. MA Avg

About Biktarvy: This combination product is used by itself to help control HIV infection. Show more ▾

It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. This product is a combination of 3 different drugs: bictegravir, emtricitabine, and tenofovir alafenamide. Bictegravir is called an integrase strand transfer inhibitor-INSTI. Emtricitabine is called a nucleoside reverse transcriptase inhibitor, while tenofovir alafenamide is called a nucleotide reverse transcriptase inhibitor. Emtricitabine and tenofovir alafenamide are often called NRTIs. Bictegravir/emtricitabine/tenofovir alafenamide is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details.

In 2024, this provider wrote 56 Medicare prescriptions for Biktarvy, about the same volume as the typical Massachusetts prescriber of this medication (54.2). Medicare paid an average of $5,644.47 per fill, versus $4,156.27 statewide.

How often this provider prescribes it

This provider
56
MA average
54.2

This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$5,644.47
MA average
$4,156.27

Gross Part D cost per fill; not the patient's out-of-pocket price.

76
30-Day Fills
standardized to 30-day supplies
2,280
Days of Medication
total across all patients in 2024

About Doxycycline Monohydrate: This medication is used to treat a wide variety of bacterial infections, including those that cause acne. Show more ▾

This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A synthetic tetracycline derivative with similar antimicrobial activity.

In 2024, this provider wrote 23 Medicare prescriptions for Doxycycline Monohydrate, about 85% of the volume of the typical Massachusetts prescriber of this medication (27.2). Medicare paid an average of $32.28 per fill, versus $12.30 statewide.

How often this provider prescribes it

This provider
23
MA average
27.2

This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$32.28
MA average
$12.30

Gross Part D cost per fill; not the patient's out-of-pocket price.

31
30-Day Fills
standardized to 30-day supplies
836
Days of Medication
total across all patients in 2024

About Atorvastatin Calcium: Atorvastatin is used along with a proper diet to help lower "bad" cholesterol and fats (such as LDL, triglycerides) and raise "good" cholesterol (HDL) in the blood. Show more ▾

It belongs to a group of drugs known as "statins." It works by reducing the amount of cholesterol made by the liver. Lowering "bad" cholesterol and triglycerides and raising "good" cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details. A pyrrole and heptanoic acid derivative, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; and TRIGLYCERIDES. It is used to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS, and for the prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors.

In 2024, this provider wrote 19 Medicare prescriptions for Atorvastatin Calcium, about 10% of the volume of the typical Massachusetts prescriber of this medication (188). Medicare paid an average of $3.81 per fill, versus $13.82 statewide.

How often this provider prescribes it

This provider
19
MA average
188.0

This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$3.81
MA average
$13.82

This provider's average cost per fill is below the MA average for this medication.

49
30-Day Fills
standardized to 30-day supplies
1,431
Days of Medication
total across all patients in 2024

About Tivicay: Dolutegravir is used with other HIV medications to help control HIV infection. Show more ▾

It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Dolutegravir belongs to a class of drugs known as integrase inhibitors. It blocks the virus from growing and infecting more cells. Dolutegravir is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. An HIV integrase inhibitor that is used in the treatment of HIV INFECTIONS in combination with other ANTI-HIV AGENTS.

In 2024, this provider wrote 15 Medicare prescriptions for Tivicay, about half the volume of the typical Massachusetts prescriber of this medication (33.2). Medicare paid an average of $2,023.80 per fill, versus $2,454.13 statewide.

How often this provider prescribes it

This provider
15
MA average
33.2

This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$2,023.80
MA average
$2,454.13

This provider's average cost per fill is below the MA average for this medication.

15
30-Day Fills
standardized to 30-day supplies
438
Days of Medication
total across all patients in 2024

About Odefsey: This product contains 3 different medications: emtricitabine, rilpivirine, and tenofovir alafenamide. Show more ▾

It is used to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Emtricitabine and tenofovir alafenamide belong to a class of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs). Rilpivirine belongs to a class of drugs known as non-nucleoside reverse transcriptase inhibitors (NNRTIs). Emtricitabine/rilpivirine/tenofovir alafenamide is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details.

In 2024, this provider wrote 14 Medicare prescriptions for Odefsey, about half the volume of the typical Massachusetts prescriber of this medication (25.9). Medicare paid an average of $3,806.45 per fill, versus $3,841.34 statewide.

How often this provider prescribes it

This provider
14
MA average
25.9

This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$3,806.45
MA average
$3,841.34

This provider's average cost per fill is below the MA average for this medication.

14
30-Day Fills
standardized to 30-day supplies
420
Days of Medication
total across all patients in 2024
No medications match the current filters.
▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average MA prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the MA average cost per fill.

About this data. The prescription history for GABRIELA CRISTINA MILLA GODOY MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Internal Medicine prescribing approach at this Boston, MA practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among MA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.